Approvals/CIMA-AEMPS/VENLAFAXINA RETARD DAVURGAMA 150 MG CAPSULAS DE LIBERACION PROLONGADA

Approved

STANDARD

VENLAFAXINA RETARD DAVURGAMA 150 MG CAPSULAS DE LIBERACION PROLONGADA

Teva Pharma S.L.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 7e8671d31f63266b
Drug Cima Aemps Name: VENLAFAXINA RETARD DAVURGAMA 150 MG CAPSULAS DE LIBERACION PROLONGADA
Register Number: 87922
Holder Company Name: Teva Pharma S.L.U.
Marketing Company Name: Teva Pharma S.L.U.
Authorization Date: 2022-07-01
Dosage Form: CÁPSULA DURA DE LIBERACIÓN PROLONGADA
Dose: 150 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Teva Pharma S.L.U.

VENLAFAXINA HIDROCLORURO

170,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 1, 2022

Approval ID

7e8671d31f63266b

Type

Standard